Legal Notice
Trademark Disclaimer
WeightLossRankings.org is an independent editorial publication. We review and compare prescription weight loss medications and telehealth providers. Because we write about real products, we use their real brand names. This page explains who owns the trademarks we reference, why we use them, and what that means for you.
The short version
Names and marks including Wegovy®, Ozempic®, and Rybelsus® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. All other product names, logos, brands, and trademarks referenced on this site are the property of their respective owners. WeightLossRankings.org uses these names only to identify the products and services discussed in our reviews, comparisons, and guides. Use of these marks does not imply endorsement, sponsorship, or affiliation. WeightLossRankings.org is not affiliated with Novo Nordisk, Eli Lilly, or any other pharmaceutical manufacturer.
Drug trademarks referenced on this site
Below are the GLP-1 and related weight loss medications we discuss, along with the companies that own the underlying trademarks.
| Mark | Owner |
|---|---|
| Wegovy® | Novo Nordisk A/S |
| Ozempic® | Novo Nordisk A/S |
| Rybelsus® | Novo Nordisk A/S |
| Mounjaro® | Eli Lilly and Company |
| Zepbound® | Eli Lilly and Company |
| Saxenda® | Novo Nordisk A/S |
| Victoza® | Novo Nordisk A/S |
| SELECT™ | Novo Nordisk A/S |
| STEP™ | Novo Nordisk A/S |
| SURMOUNT™ | Eli Lilly and Company |
Provider and program trademarks
We also review telehealth providers and weight loss programs. These names and logos are trademarks of the companies that operate those services.
| Mark | Owner |
|---|---|
| Hims® & Hers® | Hims & Hers Health, Inc. |
| Ro® | Roman Health Ventures Inc. |
| Found® | Findhealth, Inc. |
| Calibrate® | Calibrate Health, Inc. |
| Noom® | Noom, Inc. |
| WeightWatchers® / WW® | WW International, Inc. |
| Sequence® | WW International, Inc. |
| Eden® | Eden Health, Inc. |
| Mochi Health® | Mochi Health, Inc. |
This list is not exhaustive. Any other trademarks, service marks, trade names, product names, or logos appearing on WeightLossRankings.org are the property of their respective owners.
What this disclaimer means in plain English
We are not the manufacturer. WeightLossRankings.org is not Novo Nordisk, Eli Lilly, or any pharmaceutical company. We do not make, sell, ship, prescribe, or dispense any of the medications we write about.
We are not the provider. We are not Hims, Ro, Found, Calibrate, Noom, WeightWatchers, or any of the other telehealth clinics and programs we review. We are an independent editorial site.
We use brand names only to identify products. When we say “Wegovy” or “Mounjaro,” we mean the specific FDA-approved product sold under that name. This is known as nominative fair use: you can't meaningfully compare weight loss drugs without naming them.
Manufacturers have not endorsed our content. Nothing we publish has been reviewed, approved, or endorsed by Novo Nordisk, Eli Lilly, or any trademark holder. Any opinions, rankings, or evaluations represent our independent editorial judgment.
Reviews are our opinion, not the manufacturer's. Our provider rankings and drug guides reflect our scoring methodology and editorial perspective. They do not represent the views of any trademark holder.
Generic names versus brand names
Every prescription drug has both a chemical (generic) name and one or more brand names. The generic name identifies the active ingredient and is not a trademark. The brand name is a trademark owned by the manufacturer. We use both throughout the site, and they are not interchangeable in a legal sense.
- Semaglutide is the generic name for the active molecule sold by Novo Nordisk under the brand names Wegovy® (for weight management), Ozempic® (for type 2 diabetes), and Rybelsus® (oral formulation).
- Tirzepatide is the generic name for the active molecule sold by Eli Lilly under the brand names Mounjaro® (for type 2 diabetes) and Zepbound® (for weight management).
- Liraglutide is the generic name for the molecule previously sold as Saxenda® (for weight management) and Victoza® (for type 2 diabetes).
When we write about “compounded semaglutide” or “compounded tirzepatide,” we are referring to the active pharmaceutical ingredient prepared by a licensed compounding pharmacy under Section 503A or 503B of the Federal Food, Drug, and Cosmetic Act. Compounded medications are not Wegovy®, Ozempic®, Rybelsus®, Mounjaro®, or Zepbound®. They are separate preparations that contain the same active molecule. We take care to make this distinction clear wherever we discuss compounded GLP-1 products.
Source of trademark information
Trademark ownership information on this page is based on public records from the United States Patent and Trademark Office. You can verify any U.S. trademark registration yourself using the USPTO Trademark Electronic Search System (TESS):
Trademark registrations change over time. If you notice an inaccuracy on this page, please let us know using the contact information below and we will correct it.
Reporting trademark concerns
If you are a trademark holder, an authorized agent of a trademark holder, or legal counsel representing a trademark holder, and you believe WeightLossRankings.org is using your mark inappropriately, please contact us at hello@weightlossrankings.org with the subject line Trademark Concern. Please include the specific mark, the registration number if applicable, the URL of the page in question, and a description of the concern. We review all trademark correspondence and will respond within 5 business days.
Related policies: Affiliate Disclosure · Methodology · About · Terms · Privacy
Last reviewed: April 2026. This notice is provided for informational purposes and is not legal advice.